A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
Cabergoline is a long-acting dopamine-agonist drug that suppresses prolactin secretion and restores gonadal function in women with hyperprolactinemic amenorrhea. We designed a study to compare its safety and efficacy with those of bromocriptine, which has been the standard therapy. A total of 459 wo...
Main Authors: | Ismail, I.S., Webster, J., Piscitelli, G., Polli, A., Ferrari, C.I., Scanlon, M.F. |
---|---|
Format: | Article |
Language: | English |
Published: |
Massachusetts Medical Society
1994
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/10438/1/A_COMPARISON_OF_CABERGOLINE_AND_BROMOCRIPTINE_IN_THE_TREATMENT.pdf |
Similar Items
-
THE EFFECT OF BROMOCRIPTINE ON C-REACTIVE PROTEIN IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA
by: Isam Hamo Mahmood
Published: (2008-06-01) -
The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders an open, uncontrolled, multicentre study
by: Ismail, I.S., et al.
Published: (1993) -
Cabergoline or bromocriptine for prolactinoma?
by: Nicolás Triantafilo, et al.
Published: (2016-09-01) -
Endocrine and metabolic effects of growth hormone treatment
by: Ismail, I.S., et al.
Published: (1993) -
A Combination of Exercise and Therapy with Cabergoline Attenuate Disturbances of Pituitary-Gonadal Hormones in Hyperprolactinemic Male Patients
by: Mohammad Fayiz AbuMoh'd, et al.
Published: (2020-07-01)